We are live on ! Find out more
MRNA icon

Moderna
MRNA

775 hedge funds and large institutions have $22.3B invested in Moderna in 2026 Q2 according to their latest regulatory filings, with 147 funds opening new positions, 256 increasing their positions, 235 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 147 | Existing positions closed: 83

42% more capital invested

Capital invested by funds: $15.6B → $22.3B (+$6.64B)

13% more funds holding in top 10

Funds holding in top 10: 8 → 9 (+1)

7% more funds holding

Funds holding: 723 → 775 (+52)

2.2% more ownership

Funds ownership: 77.99% → 80.2% (+2.2%)

9% more repeat investments, than reductions

Existing positions increased: 256 | Existing positions reduced: 235

4% less call options, than puts

Call options by funds: $1.75B | Put options by funds: $1.81B

Holders
775
Holders Change
+52
Holders Change %
+7.19%
% of All Funds
9.36%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.11%
New
147
Increased
256
Reduced
235
Closed
83
Calls
$1.75B
Puts
$1.81B
Net Calls
-$66.5M
Net Calls Change
+$61.7M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$320M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$251M
3
Capital World Investors
Capital World Investors
California
+$185M
4
BAMCO Inc
BAMCO Inc
New York
+$103M
5
Morgan Stanley
Morgan Stanley
New York
+$55.2M

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$181M
2
First Trust Advisors
First Trust Advisors
Illinois
-$123M
3
Goldman Sachs
Goldman Sachs
New York
-$99.9M
4
Two Sigma Investments
Two Sigma Investments
New York
-$97.9M
5
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$92M
Name Holding Trade Value Shares
Change 		Change in
Stake
HC
676
Hurley Capital
New York
$4.48K – – –
RWM
677
Raffa Wealth Management
District of Columbia
$4.41K +$673 +13 +26%
BHWM
678
Bay Harbor Wealth Management
Maryland
$4.27K +$673 +13 +27%
IWM
679
IMG Wealth Management
Florida
$4.27K +$1.86K +36 +144%
AT
680
Arlington Trust
Alabama
$4.2K – – –
GEA
681
Glen Eagle Advisors
New Jersey
$3.99K +$517 +10 +21%
MNA
682
Manning & Napier Advisors
New York
$3.9K +$2.9K +56 New
IA
683
IFS Advisors
Kansas
$3.85K – – –
GIA
684
GHP Investment Advisors
Colorado
$3.78K – – –
CFM
685
Compass Financial Management
Florida
$3.64K +$2.69K +52 New
KFI
686
Key Financial Inc
Pennsylvania
$3.57K – – –
DWM
687
Dogwood Wealth Management
Kansas
$3.57K +$1.86K +36 +240%
BFPW
688
BOK Financial Private Wealth
Colorado
$3.57K +$2.64K +51 New
CSB
689
City State Bank
Iowa
$3.5K – – –
HPC
690
HM Payson & Co
Maine
$3.5K – – –
MCI
691
MRP Capital Investments
Georgia
$3.5K +$2.59K +50 New
TWD
692
True Wealth Design
Ohio
$3.5K +$2.59K +50 New
SRCM
693
Signature Resources Capital Management
California
$3.29K +$776 +15 +47%
BFS
694
Bare Financial Services
Pennsylvania
$3.22K -$828 -16 -26%
BCM
695
Blume Capital Management
California
$3.15K – – –
SWIM
696
Smallwood Wealth Investment Management
New Jersey
$2.87K – – –
CCMI
697
Creative Capital Management Investments
California
$2.87K +$2.12K +41 New
SIC
698
Salem Investment Counselors
North Carolina
$2.8K – – –
DWS
699
Dynamic Wealth Strategies
California
$2.8K – – –
NB
700
NBT Bank
New York
$2.8K – – –
26 27
28
29 30

MRNA Hedge Fund Activity: Q2 2026 in Review

775 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q2 2026, worth a combined $22.3B — up 42% from $15.6B a quarter earlier.

Buyers outnumbered sellers: 147 funds opened new MRNA positions and 83 closed out — a net gain of 64 holders — while 256 added to existing stakes and 235 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $320M. The largest seller was Alyeska Investment Group, cutting an estimated $181M.

  • 775 institutional investors held Moderna (MRNA) as of Q2 2026, up from 723 in Q1 2026.
  • Funds reported $22.3B of Moderna stock for Q2 2026, up 42% quarter-over-quarter.
  • 147 funds opened new Moderna positions in Q2 2026 and 83 closed out, a net change of +64 holders.
  • The largest Moderna buyer in Q2 2026 was Fidelity Investments, an estimated $320M added.
  • The largest Moderna seller in Q2 2026 was Alyeska Investment Group, an estimated $181M sold.

Based on aggregated 13F filings for Q2 2026.